Table 1 Demographic and clinical characteristics
Dexamethasone group n = 54 | Placebo group n = 62 | p value | |
|---|---|---|---|
Demographic characteristics | |||
Age (year) | 67.4 (9.4) | 67.1 (9.8) | 0.900 |
Male sex | 43 (79.6) | 49 (79.0) | 0.937 |
Body mass index (kg m− 2) | 27.4 (3.3) | 27.7 (3.4) | 0.618 |
Elementary education | 13 (24.0) | 8 (12.9) | 0.176 |
Secondary education | 34 (63.0) | 40 (64.5) | |
Higher education | 7 (13.0) | 14 (22.6) | |
Active smoking | 18 (33.3) | 21 (33.9) | 0.946 |
Clinical characteristics | |||
General anesthesia | 9 (16.7) | 15 (24.2) | 0.322 |
Hypertension | 42 (77.8) | 43 (69.4) | 0.307 |
Insulin-dependent diabetes mellitus | 3 (5.6) | 4 (6.5) | 0.294 |
Noninsulin-dependent diabetes mellitus | 10 (18.5) | 19 (30.6) | |
Hyperlipidemia | 40 (74.1) | 47 (75.8) | 0.830 |
Carotid artery disease | 30 (55.5) | 37 (59.6) | 0.657 |
Peripheral vascular disease | 6 (11.1) | 6 (9.7) | 0.800 |
Atrial fibrillation | 10 (18.5) | 9 (14.5) | 0.561 |
Myocardial infarction | 22 (40.7) | 26 (41.9) | 0.896 |
Left ventricular ejection fraction (%) | 60.8 (13.0) | 60.6 (10.8) | 0.924 |